Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
BloodGPT is an AI blood test interpretation platform for individuals, families, doctors, small clinics, labs, and large healthcare organizations. Its core function is not simply chat: it parses uploaded blood test data from PDFs, HL7, CSV, FHIR, and other formats into structured biomarkers, then generates readable health explanations, trend analysis, and reports.
The platform claims to use a multi-agent system and three specialized LLMs, combined with deterministic numeric extraction, threshold logic, clinical reference standards, LOINC mapping, and unit/name normalization. Typical outputs include explanations of abnormal markers, color-coded indicators, long-term trends, doctor visit preparation, diet and lifestyle suggestions, retesting recommendations, and PDF versions for both doctors and patients. For institutional users, it also supports white-label reports, role-based permission portals, JSON+PDF delivery, API access, HL7/FHIR, LIS/EHR/EMR integrations, and on-premises deployment.
There are two conflicting sets of pricing information for the personal plan in the text: one lists $9.99/$13.99/$17.99 per month, while another lists $5.99/$9.99/$15.99 per month. Both mention up to 10 uploads per profile per month. The doctor plan is $79.99/month or $800/year and includes 100 patient analyses per month. Labs are billed per biomarker, ranging from $0.05 to $0.01-$0.02/biomarker. B2B customers are offered a free pilot, sandbox, and integration support.
The main strengths are its highly focused blood test use case, covering parsing, standardization, trend tracking, and report automation, along with an emphasis on HIPAA, GDPR, SOC 2, and not using user data to train models. The drawbacks are inconsistent pricing information, a lack of independently verified details in the main text for accuracy claims such as “Stanford 100%,” the fact that medical advice cannot replace a doctor, and unclear Chinese-language quality.
BloodGPT is suitable for individuals and families who track blood tests over time, doctors who want to save time on interpretation, and labs looking to automate white-label report generation. Access from China, payment methods, and local compliance have not been disclosed, so china_access can only be marked as unknown. If use from mainland China is limited, alternatives include report interpretation tools provided by hospitals or health checkup centers, medical information systems, or general AI assistance, but medical decisions should still be based on a doctor’s judgment.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on bloodgpt.com official site.
bloodgpt.com is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach bloodgpt.com directly.